paclitaxel has been researched along with Cancer of Granulosa Cells in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Ding, Y; Ma, L; Zhang, L; Zhuang, Y | 1 |
| Li, B; Song, Y; Zhang, Y; Zhao, D | 1 |
| Aittokallio, T; Andersson, N; Anttonen, M; Bützow, R; Färkkilä, A; Haltia, UM; Heikinheimo, M; Kallioniemi, O; Kankainen, M; Kulesskiy, E; Leminen, A; Riska, A; Tang, J; Unkila-Kallio, L; Wennerberg, K; Yadav, B | 1 |
| Kesterson, JP; Lele, S; Mhawech-Fauceglia, P | 1 |
| Blagden, S; Gabra, H; Graham, J; Sharma, R | 1 |
1 trial(s) available for paclitaxel and Cancer of Granulosa Cells
| Article | Year |
|---|---|
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome | 2011 |
4 other study(ies) available for paclitaxel and Cancer of Granulosa Cells
| Article | Year |
|---|---|
A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature: Case report and review of literature.
Topics: Abdominal Cavity; Antineoplastic Agents; Ascites; CA-125 Antigen; Chemotherapy, Adjuvant; Female; Granulosa Cell Tumor; Humans; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Salpingo-oophorectomy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult | 2018 |
Outcomes of fertility-sparing surgery in ovarian juvenile granulosa cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Fertility Preservation; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dasatinib; Drug Screening Assays, Antitumor; Drug Synergism; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; TOR Serine-Threonine Kinases | 2017 |
The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Ascites; Bevacizumab; Female; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Paclitaxel | 2008 |